B.Sc. (Biology), University of Nottingham
D.Phil. (Physiology, Anatomy and Genetics), University of Oxford
Senior Research Scientist, Vancouver Prostate Centre
Assistant Professor, Department of Urologic Sciences, University of British Columbia
Dr. Wyatt is a molecular biologist with strong academic history in translational prostate cancer genomics and bioinformatics. He obtained a DPhil (PhD) in from the University of Oxford in the UK and carried out his postdoctoral training at the Vancouver Prostate Centre in Canada. In 2015 Dr. Wyatt was appointed to Assistant Professor at the University of British Columbia, and as Senior Research Scientist at the Vancouver Prostate Centre. Dr. Wyatt's scientific career to-date has been characterized by innovation, collaboration and high productivity, including over 30 peer-reviewed publications by the age of 30. He has been the recipient of multiple awards including a prestigious Coalition to Cure Prostate Cancer Young Investigator Award from the Prostate Cancer Foundation and a Movember Rising Star in Prostate Cancer Research Award from Prostate Cancer Canada.
The Wyatt laboratory studies the genomics of lethal prostate cancer. Their overall objective is to use extensive experience in personalized prostate cancer genomics to enable real-time precision oncology in the clinic. To achieve the Wyatt lab performs a variety of innovative next-generation sequencing techniques on clinical specimens including tissue and liquid biopsies from men with castration-resistant prostate cancer (CRPC). Ultimately, this will facilitate development of a suite of predictive biomarkers to allow selection of the best standard therapy for each patient. It will also reveal resistance mechanisms for existing treatments, and allow prioritization of patients at third-line for treatment with novel investigative agents.
Learn more about Wyatt lab research at http://blogs.ubc.ca/wyattlab/ (opens in new window)